MIKI Takami | Department of Geriatric Medicine and Neurology, Osaka City University Graduate School of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

＜Symposium IV＞Oligomeric Aβ is the sole culprit molecule to cause Alzheimer's disease?
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment
Vitamin K_2 (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis
Long-term effect of intermittent cyclical etidronate on microarchitecture and quality of trabecular bone in an elderly woman with severe osteoporosis
Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy ; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline
Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate : advantage of free form of DPD over total DPD in predicting treatment efficacy
Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects
Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis
The administration of an active vitamin D_3 analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia

もっと見る

スポンサーリンク